Examining 5-Year Outcomes Breakthrough Titanium-Nitride-Oxide-Coated Stent Shows Promise in Long-Term Outcomes In a comprehensive analysis of 5-year outcomes from the TIDES-ACS randomized clinical trial, researchers observed...
Read More
The ATLAS trial highlights the impact of implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation. Findings show that patients with transvenous leads experience worse outcomes related to tricuspid regurgitation compared to those with subcutaneous leads. Further research is needed to explore the implications of this relationship on patient health.
Read MoreLearn about the remarkable results of the global SPIRIT 48 trial, showcasing the safety and efficacy of a novel 48-mm stent for treating diffuse coronary lesions.
Read More